Search Results
The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.
Filter your results:
Types
Topics
39 Results Found
Tariff Implications for American Health Care
A series of tariffs recently implemented could have significant implications for health care.
AHA urges Department of Commerce to enact tariff exceptions for critical minerals used in medical devices
The AHA May 16 urged the Department of Commerce to consid
AHA urges Senate Finance Committee to strengthen supply chain
The AHA May 14 urged the Senate Finance Committee to take steps to strengthen the supply chain for essential pharmaceutical and other medical products.
U.S., China temporarily agree to reduce tariffs for 90 days
The U.S. and China reached a joint agreement to temporarily reduce tariffs for 90 days, the White House announced May 12. Both countries will lower tariffs by 115% effective May 14.
AHA comments on national security investigation of pharmaceutical imports
AHA May 6 submitted comments to the Department of Commerce on its Section 232 national security investigation of pharmaceutical and pharmaceutical ingredients imports.
Trump announces reciprocal tariffs paused for 90 days
President Trump April 9 announced that reciprocal tariffs that went into effect after midnight for certain nations will be paused for 90 days, while tariffs for China would be increased to 125%.
Vetted Domestic PPE Manufacturers
Supply chain teams across the U.S. continue to face supply shortages.
FDA says hemodialysis tube shortage expected to last until fall
The Food and Drug Administration March 14 released a notice on a nationwide shortage of hemodialysis tubes expected to last through early fall.
AHA urges administration to grant exceptions for current and proposed tariffs for medications and medical supplies
The AHA late Feb. 4 told the administration that its current and proposed tariffs on Canada, Mexico and China may jeopardize the availability of vital medications and essential health care devices.
Baxter announces all manufacturing lines at NC plant have restarted
Baxter Jan. 28 announced that IV solutions production has been restarted on all manufacturing lines at its North Carolina site impacted by Hurricane Helene in October.